2 reports

The bispecific antibody constructed using contributions from both Hanmi and Innovent enables immunotherapy and targeted therapy at the same time.

  • Immunotherapy
  • Pharmaceutical
  • China
  • Company
  • Innovent Biologics, Inc.

The bispecific antibody constructed using contributions from both Hanmi and Innovent enables immunotherapy and targeted therapy at the same time.

  • Immunotherapy
  • Pharmaceutical
  • China
  • Company
  • Innovent Biologics, Inc.